首页> 美国卫生研究院文献>Oncotarget >Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy
【2h】

Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy

机译:细胞周期诱导剂联合化疗富集的大肠癌慢循环亚群的特征和功能分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The concept of cancer stem cells has been proposed in various malignancies including colorectal cancer. Recent studies show direct evidence for quiescence slow-cycling cells playing a role in cancer stem cells. There exists an urgent need to isolate and better characterize these slow-cycling cells. In this study, we developed a new model to enrich slow-cycling tumor cells using cell-cycle inducer combined with cell cycle-dependent chemotherapy in vitro and in vivo. Our results show that Short-term exposure of colorectal cancer cells to chemotherapy combined with cell-cycle inducer enriches for a cell-cycle quiescent tumor cell population. Specifically, these slow-cycling tumor cells exhibit increased chemotherapy resistance in vitro and tumorigenicity in vivo. Notably, these cells are stem-cell like and participate in metastatic dormancy. Further exploration indicates that slow-cycling colorectal cancer cells in our model are less sensitive to cytokine-induced-killer cell mediated cytotoxic killing in vivo and in vitro. Collectively, our cell cycle inducer combined chemotherapy exposure model enriches for a slow-cycling, dormant, chemo-resistant tumor cell sub-population that are resistant to cytokine induced killer cell based immunotherapy. Studying unique signaling pathways in dormant tumor cells enriched by cell cycle inducer combined chemotherapy treatment is expected to identify novel therapeutic targets for preventing tumor recurrence.
机译:已经在包括结肠直肠癌在内的各种恶性肿瘤中提出了癌症干细胞的概念。最近的研究表明,静态慢循环细胞在癌症干细胞中起作用的直接证据。迫切需要分离并更好地表征这些慢循环细胞。在这项研究中,我们开发了一种新模型,可利用细胞周期诱导剂结合细胞周期依赖性化疗在体外和体内富集慢循环肿瘤细胞。我们的结果表明,结直肠癌细胞短期暴露于化学疗法与细胞周期诱导剂相结合,可使细胞周期静态肿瘤细胞群体富集。具体而言,这些缓慢循环的肿瘤细胞在体外表现出增加的化学抗性,在体内表现出致癌性。值得注意的是,这些细胞类似于干细胞并参与转移性休眠。进一步的研究表明,在我们的模型中,慢循环的结直肠癌细胞对体内和体外对细胞因子诱导的杀伤细胞介导的细胞毒性杀伤的敏感性较低。总的来说,我们的细胞周期诱导剂联合化疗暴露模型丰富了对细胞因子诱导的基于杀伤细胞的免疫疗法具有抵抗力的慢循环,休眠,化学耐药的肿瘤细胞亚群。在通过细胞周期诱导剂联合化学疗法治疗而富集的休眠肿瘤细胞中研究独特的信号传导途径,有望确定预防肿瘤复发的新治疗靶点。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号